Global prescription sales up 6.4%: IMS Health

Share this article:

According to an IMS Health report, global prescription sales topped $712 billion in 2007, a 6.4% growth.

The US remains the single largest market, at $286.5 billion, despite its “lowest-ever level” of contribution to global growth in 2007, at 25.5%.  Total prescription sales in the US grew 3.8%, according to the report.

Asian (excluding Japan, including Australia and New Zealand) and Latin American markets saw the most expansion last year, posting 13.3% and 11.6% growths respectively.  China grew by 25.7%.

In the US, lipid regulators for cholesterol were the top-selling therapeutic class, at $18.4 billion, while anti-depressants represented the largest therapeutic class by dispensed prescriptions, at 232.7 million, according to the IMS data.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.